Wikisage, the free encyclopedia of the second generation, is digital heritage

Topiramate: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
m (Under_construction_icon.png)
Line 1: Line 1:
topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital</ref>
topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital</ref>
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref>
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref>
 
<gallery>File:Under_construction_icon.png</gallery>
{{Wikidata|Q}}
{{Wikidata|Q}}
==Links==
==Links==

Revision as of 03:21, 18 April 2016

topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]

Q at Wikidata  Interwiki via Wikidata

Links

Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy

  1. Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital
  2. http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract